At present, combination with DPP-4 inhibitors is not recommended, despite the significant glycemic improvement, in view of the enhanced hypoglycemic effects
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
Upper is for very active or strength-training folks about 1.6 to 2.0 g/kg/day, or 0.73 to 0.9 g/lb
Prior to initiating saxagliptin, vildagliptin or alogliptin: Check liver and kidney function During treatment: Vildagliptin: Monitor liver function tests (LFTs) at 3-monthly intervals post-initiation for the first year and periodically thereafter
Ministry of Health
Our product line is diverse, offering 9 different dosage forms to cater to various consumer preferences, including capsules, tablets, gummies, syrups, powders, and drops